VBL Therapeutics SEC Filings http://ir.vblrx.com/ VBL Therapeutics SEC Filings en 6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act http://ir.vblrx.com/sec-filings/sec-filing/6-k/0001493152-19-007748 Vascular Biogenics Ltd. Fri, 17 May 2019 17:23:10 -0400 VBL Therapeutics SEC Filings 8561 424B5: Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 http://ir.vblrx.com/sec-filings/sec-filing/424b5/0001493152-19-007746 Vascular Biogenics Ltd. Fri, 17 May 2019 17:23:10 -0400 VBL Therapeutics SEC Filings 8566 6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act http://ir.vblrx.com/sec-filings/sec-filing/6-k/0001493152-19-007190 Vascular Biogenics Ltd. Wed, 15 May 2019 07:41:04 -0400 VBL Therapeutics SEC Filings 8556 20-F: Registration of securities of foreign private issuers pursuant to section 12(b) or (g) http://ir.vblrx.com/sec-filings/sec-filing/20-f/0001493152-19-004066 Vascular Biogenics Ltd. Thu, 28 Mar 2019 07:06:44 -0400 VBL Therapeutics SEC Filings 8511 SC 13G/A: An amendment to the SC 13G filing http://ir.vblrx.com/sec-filings/sec-filing/sc-13ga/0001104659-19-008595 Vascular Biogenics Ltd. Thu, 14 Feb 2019 13:48:06 -0500 VBL Therapeutics SEC Filings 8436 SC 13G/A: An amendment to the SC 13G filing http://ir.vblrx.com/sec-filings/sec-filing/sc-13ga/0000902664-19-000271 Vascular Biogenics Ltd. Thu, 17 Jan 2019 11:51:52 -0500 VBL Therapeutics SEC Filings 8431 SC 13G/A: An amendment to the SC 13G filing http://ir.vblrx.com/sec-filings/sec-filing/sc-13ga/0001535610-19-000039 Vascular Biogenics Ltd. Mon, 07 Jan 2019 07:12:45 -0500 VBL Therapeutics SEC Filings 8426 6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act http://ir.vblrx.com/sec-filings/sec-filing/6-k/0001493152-18-017660 Vascular Biogenics Ltd. Tue, 18 Dec 2018 16:09:43 -0500 VBL Therapeutics SEC Filings 8416 6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act http://ir.vblrx.com/sec-filings/sec-filing/6-k/0001493152-18-016541 Vascular Biogenics Ltd. Tue, 20 Nov 2018 07:05:06 -0500 VBL Therapeutics SEC Filings 8401 6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act http://ir.vblrx.com/sec-filings/sec-filing/6-k/0001493152-18-016323 Vascular Biogenics Ltd. Fri, 16 Nov 2018 08:50:48 -0500 VBL Therapeutics SEC Filings 8376